TP53 and cancer: It is indicate that STING-mediated IFI16 degradation can negatively regulate IFI16-mediated p53-dependent apoptosis in NSCLC, suggesting that STING has a tumor-promoting effect in some cancer types due to its potent ability to degrade IFI16 upstream [29].